FDA takes action against benzocaine in the US

24 May 2018 - Deborah Wilkes


The US Food and Drug Administration (FDA) is urging consumers not to use OTC teething products containing benzocaine because they "pose a serious risk" to infants and children younger than two years.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: